Article
Global Prevalence of Neurological Manifestations Among Patients Hospitalized with COVID-19: A Report of the Global Consortium Study of Neurologic Dysfunction in COVID-19 (GCS-NeuroCOVID) and the European Academy of Neurology [ENERGY] Registry Collaborative
2021-01-29
Abstract excerpt
Background: The novel coronavirus disease 2019 (COVID-19) pandemic continues to affect millions globally, with increasing reports of COVID-19 neurological manifestations but limited data on their population prevalence and outcome. This is the first report from two international consortia studies aimed to determine the neurological phenotypes, prevalence, and outcomes among hospitalized COVID-19 patients. <br><br>...
Topics
Open a Topic to create a Post that cites this publication.
Identifiers and source
- Literature Corpus work
- d26e2050-78a3-5b12-ac7d-dc300f7f847e
- DOI
- 10.2139/ssrn.3759712
